Cargando…

Survival in Norwegian BRCA1 mutation carriers with breast cancer

Several studies of survival in women with BRCA1 mutations have shown either reduced survival or no difference compared to controls. Programmes for early detection and treatment of inherited breast cancer, have failed to demonstrate a significant improvement in survival in BRCA1 mutation carriers. On...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hagen, Anne Irene, Tretli, Steinar, Mæhle, Lovise, Apold, Jaran, Vedå, Nina, Møller, Pål
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678098/ https://www.ncbi.nlm.nih.gov/pubmed/19366445 http://dx.doi.org/10.1186/1897-4287-7-7

Ejemplares similares

No Sib Pair Concordance for Breast or Ovarian Cancer in BRCA1 Mutation Carriers
por: Møller, Pål, et al.
Publicado: (2007)

High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series
por: Møller, Pål, et al.
Publicado: (2010)

Germline PTEN mutations are rare and highly penetrant
por: Rustad, Cecilie F, et al.
Publicado: (2006)

Screening for germline rearrangements in BRCA1 and BRCA2 in Norwegian families with breast or breast/ovarian cancer
por: Van Ghelue, M, et al.
Publicado: (2005)

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation
por: Møller, Pål, et al.
Publicado: (2014)

Ten modifiers of BRCA1 penetrance validated in a Norwegian series
por: Heramb, Cecilie, et al.
Publicado: (2015)

BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations
por: Borg, Åke, et al.
Publicado: (1999)

Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers
por: Grindedal, Eli Marie, et al.
Publicado: (2017)

The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populations
por: Rudkin, Teresa M, et al.
Publicado: (2006)

Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program
por: Hofvind, Solveig, et al.
Publicado: (2013)

Cancer worry among Norwegian male BRCA1/2 mutation carriers
por: Strømsvik, Nina, et al.
Publicado: (2011)

Costs and Benefits of Diagnosing Familial Breast Cancer
por: Heimdal, Ketil, et al.
Publicado: (1999)

Haplotype Analysis of Norwegian and Swedish Patients with Acute Intermittent Porphyria (AIP): Extreme Haplotype Heterogeneity for the Mutation R116W
por: Tjensvoll, Kjersti, et al.
Publicado: (2003)

Efficacy of Early Diagnosis and Treatment in Women with a Family History of Breast Cancer
por: Møller, Pål, et al.
Publicado: (1999)

BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer
por: Norum, Jan, et al.
Publicado: (2018)

One test to identify 50% of all Norwegian BRCA1 mutations
por: Møller, P, et al.
Publicado: (2000)

BRCA1 and BRCA2 mutation spectrum – an update on mutation distribution in a large cancer genetics clinic in Norway
por: Heramb, Cecilie, et al.
Publicado: (2018)

Complete Mutation Screening and Haplotype Characterization of the BRCA1 Gene in 61 Familial Breast Cancer Patients from Norway
por: Frost, Petter, et al.
Publicado: (2005)

The Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry
por: Grindedal, Eli Marie, et al.
Publicado: (2014)

Birth length and weight as predictors of breast cancer prognosis
por: Mæhle, Bjørn O, et al.
Publicado: (2010)

Mutation-Specific Survival of Inherited Breast Cancer
por: Møller, P., et al.
Publicado: (1999)

Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
por: Eisen, Andrea, et al.
Publicado: (2008)

Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study
por: Tretli, Steinar, et al.
Publicado: (2011)

Diagnostic mRNA splicing assay for variants in BRCA1 and BRCA2 identified two novel pathogenic splicing aberrations
por: Wangensteen, Teresia, et al.
Publicado: (2019)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
por: Warner, Ellen
Publicado: (2018)

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis
por: Metcalfe, Kelly, et al.
Publicado: (2014)

Uptake of Genetic Testing and Pre-Test Levels of Mental Distress in Norwegian Families with Known BRCA1 Mutations
por: Reichelt, Jon G., et al.
Publicado: (1999)

“It was an important part of my treatment”: a qualitative study of Norwegian breast Cancer patients’ experiences with mainstreamed genetic testing
por: Strømsvik, Nina, et al.
Publicado: (2022)

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Rebbeck, Timothy R, et al.
Publicado: (2008)

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011)

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2012)

Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality
por: Evans, D. G., et al.
Publicado: (2016)

Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers
por: Friedman, Eitan, et al.
Publicado: (2006)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012)

Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers
por: Sjursen, Wenche, et al.
Publicado: (2010)

Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status
por: Olafsdottir, Elinborg J., et al.
Publicado: (2020)

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI
por: Veltman, J., et al.
Publicado: (2008)

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
por: Antoniou, Antonis C, et al.
Publicado: (2006)

Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Odén, Lovisa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ac38smtla7c8n70sior09gpqq4